Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPRIEVE: Pitavastatin for CVD prevention in HIV
NCT02344290Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2015
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of pitavastatin in cardiovascular disease (CVD), sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 2015; status: completed.
02
Drugs
pitavastatin
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT02344290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02344290.